BB-025
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BB-025, covering 2026-04-06 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Study of BB-025, Alone and After BB-031, in Healthy Volunteers [Phase 1]